Sectors
IGC
IGC Pharma, Inc.
0.30
400 x 0.30
300 x 0.30
bid
ask
-
0.01
3.48%
350 @ 05:41 PM
0.30 +0.01 (1.91%)
| Ytd | 6.86% | |
| 1y | -30.42% |
0.29
day range
0.32
0.24
52 week range
0.47
| Open | 0.31 | Prev Close | 0.31 | Low | 0.29 | High | 0.32 | Mkt Cap | 30.93M |
| Vol | 606.92K | Avg Vol | 688.42K | EPS | -0.06 | P/E | N/A | Forward P/E | -3.74 |
| Beta | 1.29 | Short Ratio | 2.29 | Inst. Own | 22.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.27 | 200-d Avg | 0.29 | 1yr Est | 3.75 |
| Income Statement | |||
| Total Revenue | 265.00K | ||
| Revenues (USD) | 265.00K | ||
| Cost of Revenue | 217.00K | ||
| Gross Profit | 48.00K | ||
| Operating Expenses | 2.83M | ||
| Research and Development Expense | 1.39M | ||
| Selling, General and Administrative Expense | 1.44M | ||
| Operating Income | -2.78M | ||
| Net Income | -2.94M | ||
| Net Income Common Stock | -2.94M | ||
| Net Income Common Stock (USD) | -2.94M | ||
| Consolidated Income | -2.94M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | -2.94M | ||
| Earning Before Interest & Taxes (USD) | -2.94M | ||
| Weighted Average Shares | 100.33M | ||
| Weighted Average Shares Diluted | 100.33M | ||
| Balance Sheet | |||
| Cash and Equivalents | 545.00K | ||
| Cash and Equivalents (USD) | 545.00K | ||
| Investments | 23.00K | ||
| Investments Current | 23.00K | ||
| Trade and Non-Trade Receivables | 56.00K | ||
| Current Assets | 1.26M | ||
| Property, Plant & Equipment Net | 2.07M | ||
| Total Assets | 9.50M | ||
| Debt Current | 933.00K | ||
| Total Debt | 1.08M | ||
| Current Liabilities | 3.22M | ||
| Debt Non-Current | 149.00K | ||
| Total Liabilities | 3.36M | ||
| Accumulated Retained Earnings (Deficit) | -130.23M | ||
| Accumulated Other Comprehensive Income | -5.70M | ||
| Shareholders Equity | 6.13M | ||
| Shareholders Equity (USD) | 6.13M | ||
| Assets Non-Current | 8.23M | ||
| Total Debt (USD) | 1.08M | ||
| Goodwill and Intangible Assets | 5.51M | ||
| Inventory | 640.00K | ||
| Liabilities Non-Current | 149.00K | ||
| Trade and Non-Trade Payables | 1.62M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 56.00K | ||
| Net Cash Flow from Financing | 1.73M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 124.00K | ||
| Capital Expenditure | -5.00K | ||
| Issuance (Purchase) of Equity Shares | 1.04M | ||
| Issuance (Repayment) of Debt Securities | 691.00K | ||
| Net Cash Flow from Investing | -254.00K | ||
| Net Cash Flow from Operations | -1.35M | ||
| Effect of Exchange Rate Changes on Cash | -2.00K | ||
| Share Based Compensation | 747.00K | ||